Abstract
A case who revealed the longest duration of viral shedding (67 days) in current reports, presented complicated characteristic on the relapse of COVID-19 due to the inconsistent performance of chest radiography and SARS-CoV-2-RNA detection after discharge. Lopinavir-interferon α2b boosted ribavirin following with lopinavir boosted budesonide might be a potent treatment for viral clearance.
Keywords: Coronavirus disease 2019; Prognosis; Recovered patients; SARS-CoV-2 re-positive; Viral shedding.
All Keywords
【저자키워드】 Coronavirus disease 2019, Prognosis, viral shedding, recovered patients, SARS-CoV-2 re-positive, 【초록키워드】 COVID-19, Treatment, coronavirus disease, SARS-CoV-2, Coronavirus disease 2019, coronavirus, Prognosis, Lopinavir, viral shedding, ribavirin, discharge, viral clearance, Viral, Budesonide, recovered patients, characteristic, disease, recovered, Chest radiography, Relapse, 【제목키워드】 COVID-19, Surveillance, Patient, infected with SARS-CoV-2,
【저자키워드】 Coronavirus disease 2019, Prognosis, viral shedding, recovered patients, SARS-CoV-2 re-positive, 【초록키워드】 COVID-19, Treatment, coronavirus disease, SARS-CoV-2, Coronavirus disease 2019, coronavirus, Prognosis, Lopinavir, viral shedding, ribavirin, discharge, viral clearance, Viral, Budesonide, recovered patients, characteristic, disease, recovered, Chest radiography, Relapse, 【제목키워드】 COVID-19, Surveillance, Patient, infected with SARS-CoV-2,
{{{ 추상적인 }}}
현재 보고에서 가장 긴 바이러스 배출 기간(67일)을 밝힌 1예는 퇴원 후 흉부 방사선 촬영과 SARS-CoV-2-RNA 검출의 불일치로 인해 코로나19의 재발에 복잡한 특성을 나타냈다. Lopinavir-interferon α2b boosted ribavirin에 이어 lopinavir boosted budesonide는 바이러스 제거에 대한 강력한 치료제일 수 있습니다.
{{ 키워드: }} 코로나바이러스 질병 2019; 예지; 회복된 환자; SARS-CoV-2 재양성; 바이러스 배출.